Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 13 » default
Hepatic Medicine: Evidence and Research
- View all (156)
- Volume 14, 2022 (6)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 13, 2021
Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
Barsouk A, Thandra KC, Saginala K, Rawla P
Hepatic Medicine: Evidence and Research 2021, 13:145-146
Published Date: 30 December 2021
Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations
Owen ML, Beal EW
Hepatic Medicine: Evidence and Research 2021, 13:137-143
Published Date: 22 December 2021
The Prognostic Values of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-Hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study [Erratum]
Mahassadi AK, Anzouan-Kacou Kissi H, Attia AK
Hepatic Medicine: Evidence and Research 2021, 13:135-136
Published Date: 19 December 2021
The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study
Mahassadi AK, Anzouan-Kacou Kissi H, Attia AK
Hepatic Medicine: Evidence and Research 2021, 13:123-134
Published Date: 8 December 2021
Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Letter]
Ghanghro L
Hepatic Medicine: Evidence and Research 2021, 13:121-122
Published Date: 7 December 2021
Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
Ayelign M, Aynalem M, Berhane N
Hepatic Medicine: Evidence and Research 2021, 13:113-120
Published Date: 11 November 2021
Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
Gioia S, Riggio O, Nardelli S, d'Amati G, Ridola L
Hepatic Medicine: Evidence and Research 2021, 13:105-111
Published Date: 3 November 2021
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
Serifis N, Tsilimigras DI, Cloonan DJ, Pawlik TM
Hepatic Medicine: Evidence and Research 2021, 13:93-104
Published Date: 2 November 2021
Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life
Sivakumar T, Kowdley KV
Hepatic Medicine: Evidence and Research 2021, 13:83-92
Published Date: 28 August 2021
Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review
Zamberg I, Maillard J, Assouline B, Tomala S, Keli Barcelos G, Aldenkortt F, Mavrakanas T, Andres A, Schiffer E
Hepatic Medicine: Evidence and Research 2021, 13:71-82
Published Date: 7 August 2021
The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
Neuberger J, Cain O
Hepatic Medicine: Evidence and Research 2021, 13:59-69
Published Date: 14 June 2021
Step by Step: Managing the Complications of Cirrhosis
Perez IC, Bolte FJ, Bigelow W, Dickson Z, Shah NL
Hepatic Medicine: Evidence and Research 2021, 13:45-57
Published Date: 25 May 2021
Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis
Collins DP, Steer CJ
Hepatic Medicine: Evidence and Research 2021, 13:37-44
Published Date: 14 April 2021
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?
Dajti E, Alemanni LV, Marasco G, Montagnani M, Azzaroli F
Hepatic Medicine: Evidence and Research 2021, 13:25-36
Published Date: 18 March 2021
Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals
Elabd NS, Tayel SI, Elhamouly MS, Hassanein SA, Kamaleldeen SM, Ahmed FE, Rizk M, Gadallah AA, Ajlan SE, Sief AS
Hepatic Medicine: Evidence and Research 2021, 13:9-23
Published Date: 15 March 2021
Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
Molla Y, Wubetu M, Dessie B
Hepatic Medicine: Evidence and Research 2021, 13:1-8
Published Date: 28 January 2021